Published in J Immunol on December 15, 1999
Preterminal host dendritic cells in irradiated mice prime CD8+ T cell-mediated acute graft-versus-host disease. J Clin Invest (2002) 1.98
The role of antigen-presenting cells in triggering graft-versus-host disease and graft-versus-leukemia. Blood (2007) 1.37
Factors governing the activation of adoptively transferred donor T cells infused after allogeneic bone marrow transplantation in the mouse. Blood (2007) 0.96
Peripheral blood progenitor cell product contains Th1-biased noninvariant CD1d-reactive natural killer T cells: implications for posttransplant survival. Exp Hematol (2008) 0.85
Manipulating the immune system for anti-tumor responses and transplant tolerance via mixed hematopoietic chimerism. Immunol Rev (2008) 0.83
Intestinal helminths regulate lethal acute graft-versus-host disease and preserve the graft-versus-tumor effect in mice. J Immunol (2014) 0.79
Donor bone marrow-derived T cells inhibit GVHD induced by donor lymphocyte infusion in established mixed allogeneic hematopoietic chimeras. PLoS One (2012) 0.76
Immunoregulatory properties of ISG15, an interferon-induced cytokine. Proc Natl Acad Sci U S A (1996) 2.45
Characterization of human proliferative T cell responses to adenovirus. J Infect Dis (1995) 2.15
Rapamycin enriches for CD4(+) CD25(+) CD27(+) Foxp3(+) regulatory T cells in ex vivo-expanded CD25-enriched products from healthy donors and patients with multiple sclerosis. Cytotherapy (2007) 1.58
Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors. N Engl J Med (1990) 1.07
Graft-versus-leukaemia reactivity induced by alloimmunisation without augmentation of graft-versus-host reactivity. Nature (1979) 1.06
Human adenovirus-specific CD8+ T-cell responses are not inhibited by E3-19K in the presence of gamma interferon. J Virol (1996) 0.96
Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo. J Immunol (1983) 0.90
Meal patterns in the genetically obese Zucker rat. Physiol Behav (1977) 0.89
The replication of bovine viral diarrhea-mucosal disease virus in bovine leukocytes in vitro. Arch Gesamte Virusforsch (1973) 0.88
Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease. Bone Marrow Transplant (1993) 0.87
Graft-vs.-host and graft-vs.-leukemia reactions after delayed infusions of donor T-subsets. Biol Blood Marrow Transplant (1999) 0.86
Low-dose chemotherapy as a prelude to intensive treatment of spontaneous leukemia-lymphoma in AKR mice. J Natl Cancer Inst (1975) 0.86
Sca1(+)/Mac1(+) nitric oxide-producing cells in the spleens of recipients early following bone marrow transplant suppress T cell responses in vitro. Cell Immunol (1998) 0.84
Allogeneic bone marrow chimerism in germfree mice. 1. Prevention of spontaneous leukemia in AKR mice. Proc Soc Exp Biol Med (1973) 0.82
Use of anti-CD3 epsilon F(ab')2 fragments in vivo to modulate graft-versus-host disease without loss of graft-versus-leukemia reactivity after MHC-matched bone marrow transplantation. J Immunol (1995) 0.81
Allogeneic bone marrow chimerism in germ-free mice. IV. Therapy of "Hodgkin's-like" reticulum cell sarcoma in SJL mice. Transplantation (1976) 0.81
A decrease in graft-vs.-host disease without loss of graft-vs.-leukemia reactivity after MHC-matched bone marrow transplantation by selective depletion of donor NK cells in vivo. Transplantation (1992) 0.81
Ultrastructural examination of phytohemagglutinin stimulated lymphocytes infected with vesicular stomatitis virus. Arch Gesamte Virusforsch (1973) 0.80
Preservation of lymphokine-activated killer activity following T cell depletion of human bone marrow. Transplantation (1990) 0.79
Kinetic analysis of human IL-2 activated cytotoxic cells. Immunopharmacol Immunotoxicol (1991) 0.78
Kinetic analysis of cloned cytotoxic T lymphocyte reactivity against normal and leukaemic target cells. J Immunogenet (1987) 0.78
Manipulation of graft-versus-host disease for a graft-versus-leukemia effect after allogeneic bone marrow transplantation in AKR mice with spontaneous leukemia/lymphoma. Transplantation (1986) 0.77
Alloimmunization and adoptive immunotherapy of leukemia. Transplant Proc (1981) 0.77
The graft-versus-leukemia effect of post-transplant donor leukocyte infusion. Leuk Lymphoma (1996) 0.77
T-cell depletion in allogeneic bone marrow transplantation: progress and problems. Haematologica (1990) 0.77
Kinetic analysis of Qa-1-specific cloned cytotoxic T lymphocytes: lytic parameters and evaluation of cellular inhibition. Scand J Immunol (1987) 0.77
Inhibitory controls of feeding by the ventromedial hypothalamus. Am J Physiol (1974) 0.77
Graft versus leukemia. VI. Adoptive immunotherapy in combination with chemoradiotherapy for spontaneous leukemia-lymphoma in AKR mice. J Natl Cancer Inst (1975) 0.77
Donor natural killer (NK1.1+) cells do not play a role in the suppression of GVHD or in the mediation of GVL reactions after DLI. Biol Blood Marrow Transplant (2001) 0.77
Allogeneic bone marrow chimerism in germ-free mice. II. Prevention of reticulum cell sarcomas in SJL-J mice. Proc Soc Exp Biol Med (1974) 0.76
Hematologic and immunologic evaluation of recombinant human interleukin-6 in patients with advanced malignant disease: evidence for monocyte activation. J Immunother Emphasis Tumor Immunol (1996) 0.75
Prophylaxis of graft-vs-host disease by adoptive transfer of a class II antigen-specific murine T-cell clone. Prog Clin Biol Res (1987) 0.75
Isolation of suppressor-like T cells from bacteria-free allogeneic bone marrow chimeras. Prog Clin Biol Res (1985) 0.75
Errors made in the comprehension of simple active declarative sentences by children. Folia Phoniatr (Basel) (1975) 0.75
A class II antigen-specific T cell clone can suppress graft-versus-host reactivity in murine allogeneic bone marrow chimeras. Transplant Proc (1987) 0.75
Serotonin modulated Ca++ dependent K+ channels in alloimmune effector cell lytic function. Immunopharmacol Immunotoxicol (1989) 0.75
Alloimmunization for induction of graft-versus-leukemia reactivity in H-2-compatible donors: critical role for incompatibility of donor and alloimmunizing strains at non-H-2 loci. Transplant Proc (1983) 0.75
Graft-versus-leukemia for AKR spontaneous leukemia-lymphoma. Transplant Proc (1976) 0.75
AKR T-cell acute lymphoblastic leukemia: a model for human T-cell leukemia. Biomedicine (1977) 0.75
Reactivity of in-vitro-expanded alloimmune cytotoxic T lymphocytes and Qa-1-specific cytotoxic T lymphocytes against AKR leukemia in vivo. Transplantation (1985) 0.75
Allogeneic bone marrow chimerism in germfree mice. 3. Therapy of leukemic AKR mice. Proc Soc Exp Biol Med (1974) 0.75
Alloimmunization: induction of antileukemic reactivity without modification of anti-host reactivity in H-2-compatible mice. Transplant Proc (1980) 0.75
Growth of human tumors in lethally irradiated mice reconstituted with syngeneic fetal liver cells. Cancer (1977) 0.75
Growth of AKR T cell leukemia lymphoblasts in medium containing interleukin 2 (IL-2). In Vitro (1983) 0.75
Regulation of lymphokine-activated killer activity in T-replete and T-cell-depleted human bone marrow by interleukin 4. Exp Hematol (1991) 0.75
Migration patterns and functional activity of cloned cytotoxic T lymphocytes in syngeneic and allogeneic mice. Transplantation (1984) 0.75
Downregulation of L3T4+ cytotoxic T lymphocytes by interleukin-2. Science (1987) 0.75
Graft-versus-leukemia: allosensitization of MHC compatible donors induces antileukemic reactivity without amplification of antihost reactivity. Haematol Blood Transfus (1980) 0.75
Migration of cytotoxic effector cells. Prog Clin Biol Res (1987) 0.75
Graft versus leukemia. VIII. Selective reduction in antihost reactivity without loss of antileukemic reactivity by treatment of donor mice with lipopolysaccharide. Exp Hematol (1978) 0.75
Transplantation of hematopoietic and lymphoid cells in mice. Transplantation (1976) 0.75
Adoptive immunotherapy of spontaneous leukemia-lymphoma in AKR mice. Adv Exp Med Biol (1976) 0.75
Mitigation of graft-versus-host disease in mice by treatment of donors with bacterial endotoxin. Exp Hematol (1976) 0.75
Mouse leukemia and solid tumors treated with bone marrow grafting. Transplant Proc (1976) 0.75
Phase IA/IB evaluation of mammalian cell-derived glycosylated recombinant human interleukin (SIGOSIX) before and after cytotoxic chemotherapy. Ann N Y Acad Sci (1995) 0.75
Judgments of vocal roughness related to rate and extent of vibrato. Folia Phoniatr (Basel) (1973) 0.75